^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

MGMT unmethylation

i
Other names: MGMT, Methylated-DNA--protein-cysteine methyltransferase, 6-O-methylguanine-DNA methyltransferase, O-6-methylguanine-DNA-alkyltransferase
Entrez ID:
Related biomarkers:
1d
The impact of the subventricular zone invasion types and MGMT methylation status on tumor recurrence and prognosis in glioblastoma. (PubMed, Heliyon)
Both SVZ invasion and MGMT unmethylation negatively influenced the prognosis of patients with IDH wild-type GBM. The clinical model developed in this study accurately predicts the survival outcome, providing a basis and reference for clinical practice.
Journal
|
MGMT (6-O-methylguanine-DNA methyltransferase)
|
MGMT unmethylation
10ms
MGMT unmethylation and high levels of CD47 and TIGIT indicate a poor prognosis in adult diffuse gliomas. (PubMed, Front Immunol)
Collectively, these results showed that the MGMT unmethylation and high levels of CD47 and TIGIT are associated with a poor prognosis in ADG. Patients with high CD47 and TIGIT expression may benefit from anti-CD47 and TIGIT immunotherapy.
Journal • IO biomarker
|
MGMT (6-O-methylguanine-DNA methyltransferase) • TERT (Telomerase Reverse Transcriptase) • CD47 (CD47 Molecule) • TIGIT (T Cell Immunoreceptor With Ig And ITIM Domains 2)
|
MGMT unmethylation • CD47 overexpression • TERT mutation • CD47 expression • TIGIT expression
10ms
Prediction of MGMT promotor methylation status in glioblastoma by contrast-enhanced T1-weighted intensity image. (PubMed, Neurooncol Adv)
The sensitivities and specificities of the imaging feature, the presence of "Thickened structure," and the absence of "Methylated contrast phenotype" for predicting pMGMT unmethylation were 0.29 and 0.86 for the exploratory and 0.25 and 0.96 for the validation cohort. The present study showed that qualitative assessment of contrast-enhanced T1-weighted intensity images helps predict GBM's pMGMT methylation status.
Journal
|
MGMT (6-O-methylguanine-DNA methyltransferase)
|
MGMT unmethylation
11ms
Pyrosequencing Analysis of O-6-Methylguanine-DNA Methyltransferase Methylation at Different Cut-Offs of Positivity Associated with Treatment Response and Disease-Specific Survival in Isocitrate Dehydrogenase-Wildtype Grade 4 Glioblastoma. (PubMed, Int J Mol Sci)
Our study concludes that there is an association between MGMT unmethylation and worse TR and DSS. The 9% cut-off demonstrated a greater potential for patient survival as a function of time, which may shed light on the future need for standardization of MGMT methylation positivity parameters in PSQ.
Retrospective data • Journal
|
MGMT (6-O-methylguanine-DNA methyltransferase)
|
MGMT unmethylation • IDH wild-type
almost2years
Adjuvant Temozolomide Chemotherapy With or Without Interferon Alfa Among Patients With Newly Diagnosed High-grade Gliomas: A Randomized Clinical Trial. (PubMed, JAMA Netw Open)
Compared with the standard regimen, temozolomide plus interferon alfa treatment could prolong the survival time of patients with HGG, especially the MGMT promoter unmethylation variant, and the toxic effects remained tolerable. ClinicalTrials.gov Identifier: NCT01765088.
Clinical • Journal • IO biomarker
|
MGMT (6-O-methylguanine-DNA methyltransferase) • IFNAR1 (Interferon (alpha, beta and omega) receptor 1)
|
MGMT unmethylation
|
temozolomide
2years
A novel hypoxia-driven gene signature that can predict the prognosis and drug resistance of gliomas. (PubMed, Front Genet)
Finally, the effects of hypoxia-driven genes on temozolomide (TMZ) resistance were analyzed by western blot, CCK-8 and colony formation assay...Knockdown the expression of SHOX2 significantly reduced the TMZ-resistance induced by hypoxia in glioma cells. Ultimately, we identified six novel hypoxia-driven genes for reliable prognostic prediction in gliomas and found that SHOX2 might be a potential target to overcome the TMZ resistance induced by hypoxia.
Journal • Gene Signature
|
MGMT (6-O-methylguanine-DNA methyltransferase) • WT1 (WT1 Transcription Factor) • MMP9 (Matrix metallopeptidase 9) • HOXB2 (Homeobox B2) • HOXC6 (Homeobox C6) • MYOD1 (Myogenic Differentiation 1) • SHOX2 (SHOX Homeobox 2)
|
MGMT unmethylation
|
temozolomide
over2years
Identification of an Inflammatory Response-Related Gene Signature to Predict Survival and Immune Status in Glioma Patients. (PubMed, J Immunol Res)
Gene set enrichment analysis suggested that immune and oncogenic pathways were enriched in high-risk glioma patients. We constructed a signature composed of eight IRRGs for gliomas, which could effectively predict survival and guide decision-making for treatment.
Journal • Gene Signature • IO biomarker
|
MGMT (6-O-methylguanine-DNA methyltransferase)
|
MGMT unmethylation • IDH wild-type
3years
Perfusion CT detects alterations in local cerebral flow of glioma related to IDH, MGMT and TERT status. (PubMed, BMC Neurol)
Our study introduces and supports the changes of glioma flow perfusion may be closely related to its biological characteristics.
Journal
|
MGMT (6-O-methylguanine-DNA methyltransferase) • TERT (Telomerase Reverse Transcriptase)
|
MGMT unmethylation • TERT mutation
3years
[VIRTUAL] The Efficacy of Maximal Tumor Resection Combined With Whole Ventricle Radiotherapy in Patients With Glioblastoma Involving the Ventricle (ASTRO 2021)
We evaluated the role of whole ventricular radiotherapy (WVRT) during postoperative temozolomide-based chemoradiotherapy... WVRT reduced intraventricular failure rates in patients with tumor ventricle involvement and ventricle opening during surgery. Our results merit further prospective evaluation of WVRT in GBM.
Clinical
|
MGMT (6-O-methylguanine-DNA methyltransferase)
|
MGMT unmethylation
|
temozolomide
3years
The Efficacy of Maximal Tumor Resection Combined With Whole Ventricle Radiotherapy in Patients With Glioblastoma Involving the Ventricle. (PubMed, Int J Radiat Oncol Biol Phys)
WVRT reduced intraventricular failure rates in patients with tumor ventricle involvement and ventricle opening during surgery. Our results merit further prospective evaluation of WVRT in GBM.
Clinical • Journal
|
MGMT (6-O-methylguanine-DNA methyltransferase)
|
MGMT unmethylation
|
temozolomide
3years
Perfusion parameters derived from MRI for preoperative prediction of IDH mutation and MGMT promoter methylation status in glioblastomas. (PubMed, Magn Reson Imaging)
IDH mutation and MGMT promoter methylation status in GBMs can be assessed effectively by IVIM and DSC. Besides, D* was the independent predictor of IDH mutation status.
Retrospective data • Journal
|
MGMT (6-O-methylguanine-DNA methyltransferase)
|
MGMT promoter methylation • MGMT unmethylation
3years
Efficacy of Whole-Ventricular Radiotherapy in Patients Undergoing Maximal Tumor Resection for Glioblastomas Involving the Ventricle. (PubMed, Front Oncol)
We retrospectively reviewed the data of 382 patients with GBM who underwent surgical resection and temozolomide-based chemoradiotherapy...The MGMT-methylation status may further stratify patients who could benefit from WVRT. Further prospective evaluation of WVRT in GBM is warranted.
Clinical • Journal
|
MGMT (6-O-methylguanine-DNA methyltransferase)
|
MGMT unmethylation
|
temozolomide